Location History:
- Mystic, CT (US) (1987)
- Noank, CT (US) (1998 - 2003)
Company Filing History:
Years Active: 1987-2003
Title: Wayne A. Boettner: Innovator in Antibiotic Composition
Introduction
Wayne A. Boettner, based in Noank, Connecticut, is an accomplished inventor with a noteworthy portfolio of patents. With a total of four patents to his name, Boettner has made significant contributions to the field of antibiotic compositions, specifically focusing on azalide antibiotics. His innovations reflect a deep understanding of chemistry and a commitment to improving pharmaceutical offerings.
Latest Patents
Wayne A. Boettner's latest patents include groundbreaking work on azalide antibiotic compositions. These compositions consist of an equilibrium mixture of azalide isomers, water, and various acids. The innovative methods for preparing these compositions enhance their stability, particularly through the incorporation of water-miscible co-solvents, with propylene glycol being a preferred choice. This advancement not only improves the efficacy of the antibiotics but also contributes to the field of medicinal chemistry.
Career Highlights
Boettner is currently associated with Pfizer Corporation, a well-respected leader in the pharmaceutical industry. His role at Pfizer allows him to leverage his expertise in inventing and developing new antibiotic solutions. Throughout his career, Boettner has consistently focused on creating products that can provide improved therapeutic outcomes in the treatment of various infections.
Collaborations
In his endeavors, Boettner has had the privilege of collaborating with talented professionals such as Morgan L. Beatty and Peter C. Canning. These collaborations have undoubtedly enriched his research and innovation processes, leading to significant advancements in antibiotic formulations and a collaborative spirit that drives progress in their field.
Conclusion
Wayne A. Boettner is a notable inventor whose work on antibiotic compositions showcases his dedication to advancing medical science. With his latest patents promising enhanced stability and effectiveness of antibiotic treatments, Boettner's contributions are poised to have a lasting impact. Through his role at Pfizer Corporation and collaboration with colleagues, he continues to push the boundaries of pharmaceutical innovation.